Ideal Protein et al. have been under Companies' Creditors Arrangement Act protection in the Superior Court of Québec since 15 August 2023, when the proceedings were commenced following an application presented by Laboratoires C.O.P. Inc. The matter is carried under court file number 200-11-028737-230 in Quebec. A court officer's report was filed on the commencement date itself. The proceeding remains active, and the record to date contains no further docketed steps.
The officer filed report no. Neuvième Rapport du Contrôleur. The Debtors continue restructuring, pursuing tax refund claims through Tax Court of Canada proceedings, collecting outstanding receivables, and preparing financial and tax filings; actual cash flows show no significant cumulative variance from projections. Court file 200-11-028737-230.
Order Extending the Stay Period to November 30, 2026 (in French) was filed.
Source: Order Extending the Stay Period to November 30, 2026 (in French)
Minutes of the Court Hearing Extending the Stay of Proceedings to November 30, 2026 (in French) — Endorsement / reasons
37 earlier updates, back to 15 August 2023 — subscribers.
Debtor
Ideal Protein et al.
Monitor
EY
Bench
| Judge | Court | On this docket | Cases on record |
|---|---|---|---|
| Judge Jean-François | Superior Court of Québec | 5 orders, Feb 2024 – Dec 2025 | 6 cases on record |
| Justice Paradis | Superior Court of Québec | 5 orders, Aug 2023 – Dec 2023 | 3 cases on record |
Counsel of record
| Party | Counsel | First seen | Source |
|---|---|---|---|
| DebtorIdeal Protein et al. | McCarthy Tétrault LLP | 7 Sep 2023 | Application · 7 Sep 2023 |
| Priority class | Creditor | Amount | Source |
|---|---|---|---|
| Secured | Lender (syndicate of financial institutions, Term Loan lender) · in 2 casesTerm Loan facility financing the 2015 acquisition of Ideal Protein by the VC Group; specific collateral/security instruments not detailed in this excerpt, though the Lender is shown exercising control (segregated account) and Interim Financing is contemplated to rank ahead of/alongside it — Amount is sum of $192.2M in capital plus $17.4M in unpaid accrued interest, both stated as at June 30, 2023 (para 20.3). Elsewhere (para 5) the same debt is described in rounder prose terms as 'approximately $200M in principal, plus approximately $17.4M in unpaid accrued interest at June 30, 2023' — the exa · as of 30 Jun 2023 | $210M USD | Report of the Proposed Monitor - unofficial translation of the report. The official version can be accessed on the French portion of this site |
3 transactions · 2 closed · 1 approved — La transaction JAMP est approuvée par le Tribunal, faisant suite à la transaction Bariatrix déjà complétée.Approval, Vesting, Assignment and Sale of Certain Assets of Debtors and… · 5 Mar 2024
| Purchaser | Price | Status | Source |
|---|---|---|---|
| 15563143 Canada inc.tous les droits, titres et intérêts du Vendeur Canadien relatifs aux actifs identifiés à l'Annexe B (les « Actifs achetés ») · asset sale · agreement 14 Dec 2023 | Sealed | Closed20 Dec 2023 | Ninth Report of the Monitor (in French) |
| IPC of America Inc.the property identified in Schedule "A" hereto (the "Purchased Assets") owned by the US Vendor · asset sale · agreement 14 Dec 2023 | Sealed | Approved20 Dec 2023 | Write-off Order (in French) |
| Jamp Pharma Manufacturing inc.les actifs identifiés à l'Annexe B (les « Actifs achetés ») · asset sale · nominee/assignee: Jamp Pharma Manufacturing inc. (à titre de cessionnaire de Jamp Pharma Corporation) · agreement 9 Jan 2024 | Subscribers | Closed5 Mar 2024outside 30 Nov 2023 | Ninth Report of the Monitor (in French) |
The debtor’s own statement of its total assets and liabilities at filing is in the record — Subscribers
| Date | Document | File |
|---|---|---|
Ninth Report of the Monitor (in French)
| PDF · Subscribers | |
| Minutes of the Court Hearing Extending the Stay of Proceedings to November 30, 2026 (in French) | PDF · Subscribers | |
Order Extending the Stay Period to November 30, 2026 (in French)
| PDF · Subscribers | |
Eighth Report of the Monitor (in French)
| PDF · Subscribers | |
| Minutes of the Court Hearing Extending the Stay of Proceedings to December 2, 2025 (in French) | PDF · Subscribers | |
| Application for the Issuance of an Order Extending the Stay Period to November 30, 2026 | PDF · Subscribers | |
Application for the Issuance of an Order Extending the Stay Period to November 30, 2026 (in English)
| PDF · Subscribers | |
| Exhibit P-1 - Order extending Stay of Proceedings to November 30, 2026 (in French) | PDF · Subscribers | |
| Exhibit P-2 - Letter from the Tax Court of Canada (in English) | PDF · Subscribers | |
| Seventh Report of the Monitor (in French) | PDF · Subscribers | |
| Minutes of the Court Hearing (in French) | PDF · Subscribers | |
Order Extending the Stay of Proceedings to November 28, 2025 (in French)
| PDF · Subscribers | |
| Sixth Report of the Monitor (in French) | PDF · Subscribers | |
Application for the Issuance of an Order Extending the Stay Period to November 30, 2025
| PDF · Subscribers | |
Exhibit P-1 (in French)
| PDF · Subscribers | |
Fifth Report of the Monitor (in French)
| PDF · Subscribers | |
Approval, Vesting, Assignment and Sale of Certain Assets of Debtors and Extension of Stay Period Order (to November 30, 2024) - JAMP Transaction (in French)
| PDF · Subscribers | |
Judgment relating to write-off request (in French)
| PDF · Subscribers | |
009 Extension Order until 08-Mar-24 (in French)
| PDF · Subscribers | |
004 Fourth Report of the Monitor (in French)
| PDF · Subscribers | |
The Monitor declares that it has been advised by the Vendors and the Purchaser as to the following: (1) the APA has been executed and delivered; (2) the Purchase Price (as defined in the APA) has been paid; and (3) all conditions to the closing of the Transaction have been satisfied or waived by the parties thereto on January 5, 2024
| PDF · Subscribers | |
Approval, Vesting and Assignment Order
| PDF · Subscribers | |
Extension Order (in French)
| PDF · Subscribers | |
Write-off Order (in French)
| PDF · Subscribers | |
| Third Report of the Monitor (in French) | PDF · Subscribers | |
| Application for the Issuance of an Approval, Vesting and Assignment Order and Ancillary Measures | PDF · Subscribers | |
Order Extending the Stay of Proceedings to January 12, 2024 and Approving Amendments to the KERP
| PDF · Subscribers | |
Application for the Issuance of an Order Extending the Stay of Proceedings and Approving Amendments to the KERP
| PDF · Subscribers | |
Second Report of the Monitor (in French)
| PDF · Subscribers | |
| Service List | PDF · Subscribers | |
Minutes to Court Hearing (Safeguard Order)
| PDF · Subscribers | |
Application for the Issuance of a Safeguard Order
| PDF · Subscribers | |
Amended and Restated Initial Order, extending the Stay of proceedings to October 6, 2023 (in French)
| PDF · Subscribers | |
Order approving an investment and sale solicitation process (in French)
| PDF · Subscribers | |
Report of the Monitor - unofficial translation of the report. The official version can be accessed on the French portion of this site
| PDF · Subscribers | |
| Notice to Creditors | PDF · Subscribers | |
| List of creditors | PDF · Subscribers | |
Minutes of Hearing and Initial Order (in French)
| PDF · Subscribers | |
Motion for an Initial Order, an Amended and Restated initial Order and Approval of a Sale or Investment Solicitation Process (in French)
| PDF · Subscribers | |
Report of the Proposed Monitor - unofficial translation of the report. The official version can be accessed on the French portion of this site
| PDF · Subscribers | |
Filing titles and dates are public, and so is each filing's own page. The figures read from them are for subscribers.
CiteProceedings., “Ideal Protein et al.” (CCAA), Superior Court of Québec. Retrieved 20 September 2026, https://proceedings.ca/case/ideal-protein-et-al
Sources last checked · summary updated 9 August 2026 · Report a correction · Printed from proceedings.ca/case/ideal-protein-et-al
Facts and summaries are extracted automatically from the court filings linked on each page; the filings remain the authoritative record. Suggested corrections are reviewed against the source filings.